Normal Saline Versus Heparin Intermittent Flushing for the Prevention of Occlusion in Port-a-Cath
NCT ID: NCT05707936
Last Updated: 2023-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
192 participants
INTERVENTIONAL
2023-02-01
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
An evidence implementation of a randomized controlled trial for whether there is the difference in intermittent flushing 0.9% normal saline and heparin? Design: a single-blind randomized controlled trial
Method:
This study is based on the 5A (Ask, Acquire, Appraise, Apply, Audit) of evidence health care step, and design randomized controlled trial for evidence implementation.
We will include inpatients over 20 years-old adults in New Taipei City TuCheng Hospital, Taiwan, who need administration medicine by port-a-catcher. The sample size is 192 according to G-power software. Random allocation software has using for block randomization, would assign to group A: flushing with 0.9% normal saline 10ml, group B: flushing with 0.9% normal saline 20ml, and group C: flushing with heparin 100 USP/ml. SPSS 20.0 software for statistical analysis, mean or standard deviation, one- way ANOVA would use.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fluids in Sepsis and Septic Shock
NCT02748382
Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT)
NCT01128413
Mini Bolus for Fluid Challenge Responsiveness in the Emergency Department
NCT05369559
Safety Study of Inhaled Saline in Acute Lung Injury
NCT01713595
Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS
NCT03465085
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal saline 20 ml
Normal Saline Flush 20 ml
Normal Saline Flush 20 ml
Normal saline 10 ml
Normal Saline Flush 10 ml
Normal Saline Flush 10 ml
usual care (heparin)
Heparin Flush (1000 USP, 10ml)
Heparin Flush (1000 USP, 10ml)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Normal Saline Flush 20 ml
Normal Saline Flush 20 ml
Normal Saline Flush 10 ml
Normal Saline Flush 10 ml
Heparin Flush (1000 USP, 10ml)
Heparin Flush (1000 USP, 10ml)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chang Gung Memorial Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMRPVVM0141
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.